A suppressive effect of an Epstein-Barr virus-immortalized cell line on leukemic cells.
Kin
Y
Y
Department of Genetics, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, Japan.
Shibuya
M
M
Maru
Y
Y
D000368:Aged; D015703:Antigens, CD / Q000096:biosynthesis; D000943:Antigens, Differentiation / Q000096:biosynthesis; D015153:Blotting, Western; D002455:Cell Division; D002460:Cell Line; D002869:Chromosome Aberrations; D018920:Coculture Techniques; D017809:Fatal Outcome; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics / Q000378:metabolism; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D010677:Philadelphia Chromosome; D011233:Precipitin Tests; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014750:Vincristine / Q000627:therapeutic use
D015703:Antigens, CD; D000943:Antigens, Differentiation; D014750:Vincristine; D016044:Fusion Proteins, bcr-abl